Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideRMDResMed|
FinDog View：Bullish
| Metric | AMGN | RMD |
|---|
| Close | 376.35 | 228.25 |
| Market Cap | $203B | $32.9B |
| 1M | −10.26% | +3.58% |
| P/E (TTM) | 23.3 | 21.6 |
| Forward P/E | 16.9 | 17.4 |
| P/E 5-Yr Percentile | 27 | 10 |
| P/S | 5.4 | 5.8 |
| P/B | 17.4 | 5.0 |
| Dividend Yield | 3.21% | 1.25% |
| Latest Quarter Revenue | $10.1B | $1.5B |
| Revenue YoY | +9.5% | +8.6% |
| Gross Margin | 72.0% | 58.8% |
| Latest Quarter EPS | 4.37 | 2.64 |
| Avg Post-Earnings Move | ±5.2% | ±2.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 3.19% |
| 90-Day Net Insider Buying | −$4.1M | −$5.3M |
AMGN · Revenue, Last 8 Quarters ($B)
RMD · Revenue, Last 8 Quarters ($B)
